Citadel Advisors’s Clene CLNN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-320
Closed -$1.7K 14586
2024
Q4
$1.7K Buy
+320
New +$1.61K ﹤0.01% 14155
2024
Q3
Sell
-325
Closed -$2.31K 14322
2024
Q2
$2.31K Buy
325
+250
+333% +$1.87K ﹤0.01% 13705
2024
Q1
$638 Sell
75
-810
-92% -$7K ﹤0.01% 14287
2023
Q4
$5.25K Sell
885
-10
-1% -$87 ﹤0.01% 13442
2023
Q3
$8.88K Sell
895
-125
-12% -$1.73K ﹤0.01% 13157
2023
Q2
$17.9K Sell
1,020
-640
-39% -$12.5K ﹤0.01% 12828
2023
Q1
$37.5K Buy
1,660
+485
+41% +$12.6K ﹤0.01% 12500
2022
Q4
$23.5K Sell
1,175
-3,205
-73% -$74.4K ﹤0.01% 13010
2022
Q3
$245K Buy
+4,380
New +$290K ﹤0.01% 10011
2022
Q1
Sell
-3,050
Closed -$250K 13683
2021
Q4
$250K Sell
3,050
-2,935
-49% -$314K ﹤0.01% 11350
2021
Q3
$818K Buy
+5,985
New +$1.02M ﹤0.01% 8641

Other funds holding CLNN

Citadel Advisors's CLNN Position: Q1 2025 in Review

Citadel Advisors sold out of Clene (CLNN) in Q1 2025, closing a stake of 20,835 shares — an estimated $111K sold.

Citadel Advisors first reported a position in CLNN in Q1 2021 and held it in 11 quarters. The position peaked at $1.63M in Q2 2023. 24 funds tracked by Wall St. Rank hold CLNN as of Q1 2025.

  • Citadel Advisors reported no remaining Clene position as of Q1 2025 after selling out during the quarter.
  • Citadel Advisors sold 20,835 Clene shares in Q1 2025, an estimated $111K.
  • Citadel Advisors first reported a position in Clene in Q1 2021 and held it in 11 quarters.
  • Citadel Advisors's Clene position peaked at $1.63M in Q2 2023.
  • 24 funds tracked by Wall St. Rank held Clene as of Q1 2025.

Based on Citadel Advisors's 13F filing for Q1 2025, filed 15 May 2025.